scPharmaceuticals buy BiotechBee
Start price
29.09.22
/
50%
€6.15
Target price
31.12.24
€8.00
Performance (%)
-23.25%
End price
10.10.22
€4.72
Summary
This prediction ended on 10.10.22 with a price of €4.72. The prediction for scPharmaceuticals disappointed with a performance of -23.25%. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
scPharmaceuticals | 8.867% | 8.867% | -56.667% |
iShares Core DAX® | -0.922% | -1.078% | 12.165% |
iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% |
iShares Nikkei 225® | 2.224% | -2.825% | 19.015% |
iShares S&P 500 | -0.026% | -0.788% | 28.485% |
According to BiotechBee what are the pros and cons of scPharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread scPharmaceuticals diskutieren
Buy mit Kursziel 8,0
In the thread Trading scPharmaceuticals
Buy beendet